semaj83/ctmatch_classification huggingface dataset:
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  The Quality of Life of Parents of Children With Food Allergy Parents or caregivers who identify as having a child under the age of 18 with a food allergy The allergy has been diagnosed by a qualified physician (e.g. GP or allergy specialist) Mean score of >=2 on the FAQL-PB, indicating they are at least 'somewhat limited/troubled' by their child's allergy (Cohen et al., 2004) Resident in the United Kingdom Have access to email, a PC/laptop/tablet with a webcam and microphone and internet access to allow videoconferencing  They had consulted on the design and content of the intervention or study They have already participated in a substantial mindfulness-based course They are currently engaged or are planning to engage with another psychological intervention during the course of the study They currently engage in regular mindfulness-based practice They do not have the practical means and time available to be able to attend the intervention during the dates outlined on the information sheet and commit to at-home practice They have scores >19 on PHQ-8 (indicating 'severe' depressive symptom severity; Kroenke et al., 2009) or >15 on GAD (indicating 'severe' level of anxiety; Spitzer et al., 2006) They have a problem with alcohol or recreational drug misuse They have experienced thoughts about harming themselves or others in the last 12 months They have been given a diagnosis of psychosis They are currently experiencing high levels of distress and/or currently feeling particularly fragile
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 25.0-55.0,  Healthy age between 25-55 years less than two hours of physical training per week over the last two years before entering the study  biking for transportation more than 40 km/week diagnosed with severe diseases medical treatment with a documented effect on body composition abuse of alcohol/drugs pregnancy or breastfeeding
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  COVID-19 Vaccines Priority groups for coronavirus (COVID-19) vaccination (health and social care workers) following breastfeeding practices and receiving vaccines  cessation of breastfeeding and vaccine side-effects requiring specific treatment and/or hospitalization
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-90.0,  Neurologic Manifestations stroke patients (hemorrhagic or ischemic) documented through Magnetic Resonance Imaging (MRI) or Computed Tomography (CT); 2. NeuroCOVID19 stroke patients with double nasopharyngeal swab negative after 24 hours for SARS-Cov2. 3. latency time within 6 months after stroke event; 4. sufficient cognitive and language skills to understand the instructions related to the administration of the assessment scales and to sign informed consent; -  behavioral and cognitive disorders that may interfere with the therapeutic activity; 2. other orthopaedic or neurological complications that may interfere with the rehabilitation protocol; 3. inability to understand and sign informed consent; -
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 12.0-17.0,  Food Allergy in Children Children and Adolescents ages 12-17 years with a food allergy To have reported anxiety or worry in relation to management of food allergy Able to attend the one-day workshop at the University of Surrey to complete the intervention in full (or online alternative) Willing and able to comprehend English and provide assent/consent  Child does not speak English Able and willing to engage and understand the content of the workshop Currently under a mental health team and receiving ongoing psychological input Do not have the capacity to provide informed assent/consent and/or consent not gained from caregivers
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Peri-Implantitis subjects who were 18 years old or older at the time of intervention subjects who provided their informed consent for the intervention patients with total or partial edentulism treated with dental implants patients with at least 6 months follow-up, beginning from the date of placement of the prosthesis  Incomplete data (e.g. absence of periapical radiographs)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Alcohol Drinking Pregnancy pregnant woman over 18 years old, presenting in one of the three maternities of the study for her prenatal care and having returned her self-report and having given her written consent  woman under 18 years old or not pregnant or not having returned her self-report or woman who refused to participate in the study (absence of written consent)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Same-day Surgery All participants/patients that will undergo a partial knee replacement (PKR) procedure within one consecutive year by one high-volume surgeon (i.e. no preselection of patients will be made)  PKR procedures performed by other surgeons One-stage bilateral PKR procedures PKR procedures not given the first surgery slot of the day
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 40.0-55.0,  Vasomotor Symptoms Hot Flashes Sleep Problem Being in the perimenopausal period according to the Staging of Reproductive Aging in Women (STRAW) Women in the early menopause transition phase (STRAW -2). In these women, there is a variation in the duration of the cycles for 7 days or more Women in the late menopausal transition phase (STRAW -1). These women have amenorrhea that lasts 60 days or longer Having entered natural menopause Not receiving hormone replacement therapy in the past and / or currently Not having a diagnosed psychiatric disease Not using alcohol Not using sleeping pills Not doing any other body-mind based practice (meditation, hypnosis, yoga, mindfulness techniques-minfulness, guided imagery technique), Not having a disease that may cause sleep problems and vasomotor symptoms and not receiving medical treatment (thyroid diseases, heart failure, neurological disorders) Women health initiative insomnia scale score above 10  Failure to communicate by calling 3 times on different days during the follow-up and the woman not returning to the phone call Woman not applying PMRE and health education at most 3 times a week The woman leaves the research voluntarily
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-90.0,  Covid19 Influenza A Influenza B H1N1 Influenza Age 18-90 years Both genders Absence of infection by COVID-19, influenza H1N1, influenza A or B at the time of measurement of serum vitamin D levels Absence of infection at any site of bacterial, fungal or other origins Health worker at Hospital Clínica Nova. Patient  for both arms Serum Vitamin D levels> 100ng / ml Previous consumption of supplements containing Vitamin D3 Pregnancy
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-99.0,  Covid19 Endothelial Dysfunction Participants must be 18 years of age or older Participants must have a PCR confirming COVID 19 status Participants must be classified as critical as per the FDA evidence of critical illness, which is defined as respiratory failure requiring at least one of the following: Endotracheal intubation and mechanical ventilation, oxygen delivered by high flow nasal cannula (heated, humidified, oxygen delivered via reinforced nasal cannula at flow rates > 20 L/min with fraction of delivered oxygen ≥ 0.5), noninvasive positive pressure ventilation, ECMO, or clinical diagnosis of respiratory failure (i.e., clinical need for one of the preceding therapies, but preceding therapies not able to be administered in setting of resource limitation) Eligible for or already taking Statin  Patients who are already on statins or Nicorandil Patients labeled as having mild, moderate or severe COVID-19 infection as per the FDA definitions Patients with shock as defined by SBP<90 for more than 30 minutes not responding to IV fluids with evidence of end organ damage Severe hepatic impairment (Child-Pugh class C) or active liver disease are absolute reasons not to be included especially those with unexplained persistent elevations of serum transaminases Pregnancy or breastfeeding Hypersensitivity to any of the above-mentioned medications On Levodopa Patients on PDE5 inhibitors, Riociguat Acute pulmonary edema Hypovolemia
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 10.0-999.0,  COVID-19 Residence in one of the public housing complexes in Mott Haven, South Bronx English or Spanish-speaking Age 10 years or older Willing and able to provide informed consent or assent  Non-resident of one of the public housing complexes in Mott Haven, South Bronx Neither English nor Spanish speaker Younger than 10 years old, unless household index case tests antigen positive. In this instance, all members of family will be included Unwilling or unable to provide informed consent or assent
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Chronic Obstructive Pulmonary Disease Chronic Bronchitis Meet the diagnostic of acute exacerbation in chronic obstructive pulmonary disease or chronic bronchitis; 2. Meet the diagnostic of Phlegm-heat Syndrome (Tan-re Zheng) in TCM 3. Age from 18 to 75 years old, regardless of gender; 4. The score of each dimension of the sputum assement scale is ≥1; 5. Those who have not participated in other drug clinical research in the past one month; 6. Sign the informed consent letter  Patients with pulmonary tuberculosis, bronchial cancer or other lung diseases. 2. Loose stools due to Spleen deficiency and stomachache caused by cold. 3. Diabetes or severe cardiovascular, liver (ALT>1.5×ULN), kidney (Cr>1.5×ULN) and other primary diseases. 4. Pregnant and lactating women. 5. Patients with acute and chronic respiratory failure. 6. Those who cannot give full informed consent due to mental disorders. 7. People with disabilities recognized by law. 8. People with allergies, or allergic to the ingredients of the drug used in this test. 9. Those who have used drugs with expectorant effects within the day. 10. Patients who are participating in clinical trials of other drugs. -
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Covid19 Agree to participate in the trial by signing the IRB approved Informed Consent 2. Age ≥ 18 years of age 3. Positive diagnosis for COVID-19 by SARS-CoV-2 PCR by nasopharyngeal swab within the past 3 days 4. Two or more COVID-19 symptoms (at least one of which must be Respiratory) rated Mild or Moderate on the COVID-19 adapted FLU-PRO Plus scale 5. SpO2 ≥ 94 mm Hg 6. Ambulatory (not hospitalized) at the time of enrollment 7. At increased risk of developing more severe COVID-19 disease (at least one of the following): 1. Age ≥60 years 2. Presence of pulmonary disease, specifically moderate or severe persistent asthma, chronic obstructive pulmonary disease, pulmonary hypertension, emphysema 3. Diabetes mellitus (type 1 or 2), requiring oral medication or insulin for treatment 4. Cardiovascular disease, including Hypertension, requiring at least 1 oral medication for treatment; congestive heart failure; coronary artery disease; cardiomyopathy; pulmonary hypertension 5. Body mass index ≥30 6. Chronic renal disease (but not on dialysis) 7. Sickle cell disease or trait 8. Comorbid disease (as above) well controlled/stable in opinion of the Investigator 9. Normal (or stable if abnormal per comorbidity) baseline ECG 10. Men of child-bearing potential must use birth control with heterosexual partner(s) (abstinence or condoms) 11. Women of child-bearing potential must meet all the following Use of birth control (abstinence, oral contraceptives, condoms, or intrauterine device) Test negative for β-subunit of HCG  Pregnant or lactating 2. Treatment with COVID-19 antiviral such as remdesivir or SARS-CoV-2 antibodies 3. Prior COVID-19 vaccination or prior recovery from documented COVID-19 infection 4. Severe or Critical COVID-19, as indicated by respiratory distress or shortness of breath at rest; Resp Rate ≥30/min; Heart rate ≥125/min; SpO2 ≤ 93% on room air or PaO2/FiO2 ≤ 300 if on supplemental O2 5. Positive HIV or positive Hepatitis Panel 6. Treatment with any medications known to be strongly metabolized by CYP3A4 or CYP2D6
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.75-15.0,  Typhoid Fever In order to be eligible to participate in this study, an individual must meet the following Healthy participants aged 9 months to <16 years (i.e., ≤15 years and 364 days) of age at the time of vaccination Participants/Parents/legally authorized representative (LAR) who have voluntarily given informed assent (sought from participants aged 12 years to <16 years) and informed consent Participants/Parents/LAR living within study target area at the time of vaccination and willing to follow the study procedures and be available for the entire duration of the study  An individual who meets any of the following will be excluded from participation in this study Known allergy to any vaccine component Self-reported ongoing acute and/or chronic illness Any self-reported coagulopathies Any medical or social compelling reasons in the judgment of a clinical physician Self-reported pregnancy/Positive urine pregnancy test or lactating Previous typhoid vaccination in the last 5 years (proven by the presentation of a vaccine card or self-reporting). Temporary Self-reported fever (elevated tympanic (≥38°C) or axillary temperature (≥37.5°C)) within 24 hours of vaccination Self-reported use of antipyretics within 4hours prior to vaccination Any other vaccination during the last 4 weeks (proven by the presentation of a vaccine card or self-reporting)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 19.0-999.0,  Healthy Adult Volunteers Those who are over 19 years old at the screening visit 2. Those with a body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 with a weight of 50 kg or more (45 kg or more for women) at the screening visit 3. Those who do not have clinically significant congenital or chronic diseases and have no pathological symptoms or findings upon medical examination at the screening visit 4. Those who determined as suitable study subjects by the principal investigator (or a delegated sub-investigator) in result of planned and conducted laboratory tests such as hematology, blood chemistry, serum, and urine tests according to the characteristics of the investigational product  Those who have a clinically significant disease or have a history of such disease in the digestive system, cardiovascular system, endocrine system, respiratory system, blood/tumor, infectious diseases, kidney and genitourinary system, mental and nervous system, musculoskeletal system, immune system, otorhinolaryngology, skin system and ophthalmic system. 2) Those who have a history of gastrointestinal surgery (except for simple appendectomy or hernia surgery) that may affect the absorption of drugs or have gastrointestinal diseases 3) Those who have taken drugs that induce and inhibit metabolism enzymes such as barbital drugs within 1 month of the first administration date, or have taken drugs that may interfere with this clinical trial within 10 days of the first administration date. (However, participation is possible depending on the characteristics of pharmacokinetics and pharmacodynamics such as interactions with investigational products or half-life of concomitant drugs) 4) Those who participated in other clinical trials or bioequivalence studies and administered the investigational products within 6 months of the first administration date
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 12.0-999.0,  Hereditary Angioedema (HAE) Participant is aged >= 12 years at the time of the last documented HAE attack in the period Participant has a physician-confirmed diagnosis (or confirmation in medical records) of HAE type I or type II Participant had initiated LTP with lanadelumab during the period Participant provides informed consent or assent prior to the initiation of any study procedures (where required by local regulations)  Participant was enrolled in a therapeutic investigational drug or device trial during the observation period Participant without documented HAE attacks in the pre-index period and/or without available participant diary or systematic documentation of HAE attacks in the medical records during the post index period